Pfizer tests new Drug's safety with common medications

NCT ID NCT06837259

Summary

This early Pfizer study tested how two common medicines—an immunosuppressant and an antibiotic—affect the way the body processes a new drug called PF-07328948. It involved 26 healthy adult volunteers who stayed in a clinic to have their blood levels and safety monitored. The goal was to understand potential drug interactions before testing in patients with a disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Pfizer Clinical Research Unit - Brussels

    Brussels, Bruxelles-capitale, Région de, B-1070, Belgium

Conditions

Explore the condition pages connected to this study.